| 1 |
32606154 | Synergistic Anti-cancer Activity of MH-30 in a Murine Melanoma Model Treated With Cisplatin and its Alleviated Effects Against Cisplatin-induced Toxicity in Mice. | 2020 Jul-Aug |
2 |
| 2 |
28655574 | Cisplatin along with herbal drug treatment reduces the percentage of regulatory T cells and decreased the severity of experimental visceral leishmaniasis. | 2018 Aug |
1 |
| 3 |
22714286 | Chemotherapy broadens the range of tumor antigens seen by cytotoxic CD8(+) T cells in vivo. | 2012 Dec |
1 |
| 4 |
19292900 | Enhanced antitumor efficacy of cisplatin in combination with HemoHIM in tumor-bearing mice. | 2009 Mar 17 |
1 |
| 5 |
9520291 | Interleukin-2: hope in cases of cisplatin-resistant tumours. | 1998 Mar |
1 |
| 6 |
9024501 | Effects of granulocyte-colony-stimulating factor and interleukin-2 on ascites formation and the survival time of nude mice bearing human ovarian cancer cells. | 1996 Dec |
1 |
| 7 |
7923989 | Enhanced therapeutic effects of anti-tumour agents against growth and metastasis of colon carcinoma 26 when given in combination with interferon and interleukin-2. | 1994 Nov |
1 |
| 8 |
8509227 | Dualistic effects of cis-diammine-dichloro-platinum on the anti-tumor efficacy of subsequently applied recombinant interleukin-2 therapy: a tumor-dependent phenomenon. | 1993 May 28 |
1 |
| 9 |
3501452 | [Effects of cimetidine and PSK on interleukin-2 production by PBL in patients with advanced ovarian carcinoma during the course of chemotherapy]. | 1987 Nov |
1 |